INTRAGASTRIC BALLOON AND IMPACT ON WEIGHT LOSS: EXPERIENCE IN QUITO, EQUADOR

Overview

Journal Arq Bras Cir Dig

Specialties Gastroenterology
General Surgery

Date 2023 May 31

PMID 37255102

Authors

Jonathan Jerez

David Cabrera

Carlos Cisneros

Monica Moreno

Daniela Guaitara

Chiristian Benavides

Martha Fors

Kirsten Falcon

Affiliations

Soon will be listed here.

Abstract

Background: Obesity is associated with different medical conditions, such as cardiologic, respiratory, gastrointestinal, and genitourinary, and constitutes a severe health problem.

Aims: This study aimed to evaluate the use of intragastric fluid-filled balloon in the reduction of weight and other measurements related to body composition.

Methods: This is a retrospective, monocentric study involving all patients who opted for the intragastric balloon Spatz® placement from January 2018 to July 2019, with fulfillment of inclusion and exclusion criteria. The patients were analyzed after 6 and 12 months after the intragastric fluid-filled balloon placed.

Results: A total of 121 subjects were included in this study, with 83 (68.6%) females and 38 (31.4%) males. The mean age was 36 years and height was 1.64±0.09. Weight mean and standard deviation was 89.85±14.65 kg, and body mass index was 33.05±4.03; body mass index decreased to 29.4 kg/m2 with a mean weight of 79.83 kg, after 12 months of follow-up. There were statistical differences between body mass index and the 12 months in fat percentage, fat-free mass (kg), visceral fat area, and basal metabolic rate. There was a significant variation according to gender, with males having highest reduction. The percentage of excess weight loss was 46.19, and the total weight loss was 9.24 at the end of the study.

Conclusions: The study demonstrated a benefit of intragastric fluid-filled balloon on weight loss after 12 months. At the end of treatment, body mass index and the measurements of body composition were significantly lower. Men benefited more than women from the treatment.

Citing Articles

Medical weight loss in older persons with obesity.

Gavras A, Batsis J Clin Obes. 2024; 14(5):e12684.

PMID: 38924367 PMC: 11570349. DOI: 10.1111/cob.12684.

References

Takihata M, Nakamura A, Aoki K, Kimura M, Sekino Y, Inamori M . Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. Obes Res Clin Pract. 2014; 8(4):e331-8. DOI: 10.1016/j.orcp.2013.07.002. View

Al-Subaie S, Khalifa S, Buhaimed W, Al-Rashidi S . A prospective pilot study of the efficacy and safety of Elipse intragastric balloon: A single-center, single-surgeon experience. Int J Surg. 2017; 48:16-22. DOI: 10.1016/j.ijsu.2017.10.001. View

Abu Dayyeh B, Kumar N, Edmundowicz S, Jonnalagadda S, Larsen M, Sullivan S . ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015; 82(3):425-38.e5. DOI: 10.1016/j.gie.2015.03.1964. View

Guedes M, Fittipaldi-Fernandez R, Diestel C, Simas Torres Klein M . Changes in Body Adiposity, Dietary Intake, Physical Activity and Quality of Life of Obese Individuals Submitted to Intragastric Balloon Therapy for 6 Months. Obes Surg. 2018; 29(3):843-850. DOI: 10.1007/s11695-018-3609-x. View

Abu Dayyeh B, Edmundowicz S, Thompson C . Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies. Gastroenterology. 2017; 152(4):716-729. DOI: 10.1053/j.gastro.2017.01.035. View

Cummings D, Weigle D, Frayo R, Breen P, Ma M, Dellinger E . Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002; 346(21):1623-30. DOI: 10.1056/NEJMoa012908. View

Pinheiro J, Castro I, Ribeiro I, Ferreira M, Fireman P, Madeiro M . REPERCUSSIONS OF BARIATRIC SURGERY ON METABOLIC PARAMETERS: EXPERIENCE OF 15-YEAR FOLLOW-UP IN A HOSPITAL IN MACEIÓ, BRAZIL. Arq Bras Cir Dig. 2022; 34(4):e1627. PMC: 8846381. DOI: 10.1590/0102-672020210002e1627. View

Yorke E, Switzer N, Reso A, Shi X, de Gara C, Birch D . Intragastric Balloon for Management of Severe Obesity: a Systematic Review. Obes Surg. 2016; 26(9):2248-2254. DOI: 10.1007/s11695-016-2307-9. View

Agnihotri A, Xie A, Bartalos C, Kushnir V, Sullivan S, Islam S . Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss. Clin Gastroenterol Hepatol. 2018; 16(7):1081-1088.e1. DOI: 10.1016/j.cgh.2018.02.026. View

10.

. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View

11.

Al-Sabah S, Al-Ghareeb F, Ali D, Al-Adwani A . Efficacy of intragastric balloon for the management of obesity: experience from Kuwait. Surg Endosc. 2015; 30(2):424-429. DOI: 10.1007/s00464-015-4212-z. View

12.

Sallet J, Marchesini J, Paiva D, Komoto K, Pizani C, Ribeiro M . Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004; 14(7):991-8. DOI: 10.1381/0960892041719671. View

13.

Martins Fernandes Jr F, Carvalho G, Lima D, Rao P, Shadduck P, Montandon I . Intragastric Balloon for Overweight Patients. JSLS. 2016; 20(1). PMC: 4777670. DOI: 10.4293/JSLS.2015.00107. View

14.

Sekino Y, Imajo K, Sakai E, Uchiyama T, Iida H, Endo H . Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese patients. Intern Med. 2011; 50(21):2449-55. DOI: 10.2169/internalmedicine.50.5672. View

15.

Genco A, Cipriano M, BACCI V, Cuzzolaro M, Materia A, Raparelli L . BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2005; 30(1):129-33. DOI: 10.1038/sj.ijo.0803094. View

16.

Gaur S, Levy S, Mathus-Vliegen L, Chuttani R . Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc. 2015; 81(6):1330-6. DOI: 10.1016/j.gie.2015.01.054. View

17.

Mui W, Ng E, Tsung B, Lam C, Yung M . Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2008; 20(8):1128-32. DOI: 10.1007/s11695-008-9766-6. View

18.

Donadio F, Sburlati L, Masserini B, Lunati E, Lattuada E, Zappa M . Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients. J Endocrinol Invest. 2009; 32(2):165-8. DOI: 10.1007/BF03345708. View

19.

Ribeiro da Silva J, Proenca L, Rodrigues A, Pinho R, Ponte A, Rodrigues J . Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy. GE Port J Gastroenterol. 2018; 25(5):236-242. PMC: 6170907. DOI: 10.1159/000485428. View

20.

Dastis N, Francois E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M . Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy. 2009; 41(7):575-80. DOI: 10.1055/s-0029-1214826. View